Lumileds has an estimated enterprise value of USD 2 billion, including debt and debt-like items. The sale of Lumileds, which has been operating as a standalone company within Philips since early 2015, is in line with Philips’ strategic focus on healthcare. Philips will retain the remaining 19.9% interest in Lumileds.
This is the second time this year that De Brauw has advised Philips on a large transaction, following Philips Lighting’s IPO in May 2016.
Arne Grimme (lead partner), Dieter Wolff, Yi Duan, Heleen Koggink and Michelle Massart